conatumumab
oleclumab
panitumumab
mapatumumab
drozitumab
patritumab
lintuzumab
matuzumab
tenatumomab
onartuzumab
naptumomab estafenatox
lexatumumab
duligotuzumab
inotuzumab
sibrotuzumab
dacetuzumab
inotuzumab ozogamicin
tigatuzumab
dalotuzumab
nofetumomab
figitumumab
lucatumumab
pamrevlumab
acrixolimab
adecatumumab
iratumumab
teprotumumab
pritumumab
avelumab
agonistic monoclonal antibody
durvalumab
ocrelizumab
sonepcizumab
tucotuzumab
samalizumab
elotuzumab
brentuximab
carlumab
apolizumab
brolucizumab
tislelizumab
pidilizumab
ravulizumab
abagovomab
gevokizumab
olaratumab
cergutuzumab
bivatuzumab
intetumumab
ipilimumab